---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-010502"
form_type: "8-K"
ticker: "NXTS"
cik: "0001789192"
company_name: "Nexentis Technologies Inc."
filed_at: "2025-03-17T23:59:59+00:00"
generated_at: "2026-05-24T16:02:44.312677+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# N2OFF loans $250K to MitoCareX, pending acquisition funding

## Summary
- $250,000 loan to MitoCareX Bio Ltd., 6-month term, interest at Israel tax rate + 3%.
- Loan guaranteed by L.I.A. Pure Capital Ltd.
- Second $250K loan to MitoCareX; prior loan dated Dec 22, 2024.
- Loan intended to cover MitoCareX costs until closing of Feb 2025 acquisition agreement.
- If acquisition closes, outstanding loan amount deducted from first-year allocation to MitoCareX.

## SEC filing metadata
- accession: 0001493152-25-010502
- form_type: 8-K
- ticker: NXTS
- cik: 0001789192
- company_name: Nexentis Technologies Inc.
- filed_at: 2025-03-17T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1789192/000149315225010502/0001493152-25-010502-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1789192/000149315225010502/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-010502
- JSON: https://secwatch.observer/filing/0001493152-25-010502.json
- Plain text: https://secwatch.observer/filing/0001493152-25-010502.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.